【レポートの概要（一部）】
1. Executive Summary
1.1 The Global Osteoporosis Drug Market Review
1.2 The Global Osteoporosis Drug Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to Osteoporosis
2.1 Osteoporosis Prevalence and Incidence, 2014
2.2 Osteoporosis: The Silent Killer
2.3 Osteoblasts are Critical in Bone Healing
2.4 Classifying Osteoporosis by Types
2.5 Classifying Osteoporosis by Treatments
2.5.1 Antiresorptive Medication
2.5.2 Anabolic Medication
2.6 Osteoporosis Risk Factors
3. The Global Osteoporosis Drug Market, 2014-2024
3.1 Scope of this Report
3.2 The Global Osteoporosis Drug Market in 2013
3.3 The Global Osteoporosis Drug Market: Sales Forecast 2014-2024
3.4 Breakdown of the World Osteoporosis Drug Market by Therapeutic Classes, 2013
3.5 The Global Osteoporosis Drug Market by Therapeutic Classes: Sales Forecast 2014-2024
3.6 Breakdown of the World Osteoporosis Drug Market by Leading Drugs, 2013
3.6.1 The Global Osteoporosis Drug Market by Leading Drugs: Sales Forecast 2014-2024
3.7 Which Osteoporosis Drugs Will Lead the Market in 2024?
3.7.1 Osteoporosis Products Pipeline, 2014
3.7.2 Forteo (Teriparatide) -Eli Lilly, 2014
3.7.3 Evista(Raloxifene) – Eli Lilly, 2014
3.7.4 Prolia (Denosumab) – Amgen, GSK and Daiichi Sankyo, 2014
3.7.5 Actonel/Atelvia (Risendronate) -Sanofi, Actavis, Ajinomoto Pharmaceuticals and Eisai, 2014
3.7.6 Fosamax (Alendronate) – Merck, 2014
3.7.7 Reclast/Aclasta (Zoledronic Acid) – Novartis, 2014
3.7.8 Boniva (Ibandronate) –Roche and GSK, 2014
3.7.9 Duavee (Bazedoxifene/Conjugated Estrogens) – Pfizer and Ligand Pharmaceuticals, 2014
3.7.10 Odanacatib (MK 0822) – Merck, 2014
3.7.11 Romosozumab (AMG 785) – Amgen and UCB, 2014
3.7.12 The Global Osteoporosis Drug Market: Drivers and Restraints 2014-2024
4. Leading National Osteoporosis Drug Markets, 2014-2024
4.1 Regional Breakdown of the World Osteoporosis Drug Market, 2013
4.2 Regional Breakdown of the World Osteoporosis Drug Market: Sales Forecast by Region, 2014-2024
4.3 How Will Regional Market Shares Change to 2024?
4.4 The US Osteoporosis Drug Market, 2013
4.4.1 The US Osteoporosis Drug Market: Forecast 2014-2024
4.5 Reimbursement Situation in the US, 2014
4.5.1 The US Keeps Dominating the Osteoporosis Drug Market: What About Healthcare Coverage?
4.6 The US Osteoporosis Drug Market: Drivers and Restraints, 2014-2024
4.7 The Leading European Osteoporosis Drug Markets, 2013
4.7.1 The Leading European Osteoporosis Drug Markets: Forecasts 2014-2024
4.7.2 The German Osteoporosis Drug Market Forecast, 2014-2024
4.7.3 The French Osteoporosis Drug Market Forecast, 2014-2024
4.7.4 The UK Osteoporosis Drug Market Forecast, 2014-2024
4.7.5 The Italian Osteoporosis Drug Market Forecast, 2014-2024
4.7.6 The Spanish Osteoporosis Drug Market Forecast, 2014-2024
4.8 The Japanese Osteoporosis Drug Market, 2013
4.8.1 The Japanese Osteoporosis Drug Market Forecast, 2014-2024
4.8.2 Recent Trends in the Japanese Osteoporosis Drug Market, 2014
4.9 The BRICK Countries Osteoporosis Drug Market, 2013
4.9.1 The BRICK Countries Osteoporosis Drug Market Forecast, 2014-2024
4.9.2 The Chinese Osteoporosis Drug Market Forecast, 2014-2024
4.9.2.1 Main Companies in the Chinese Osteoporosis Drug Market, 2014
4.9.2.2 Growth Drivers in the Chinese Osteoporosis Drug Market, 2014-2024
4.9.3 The Indian Osteoporosis Drug Market Forecast, 2014-2024
4.9.4 The Russian Osteoporosis Drug Market Forecast, 2014-2024
4.9.5 The Brazilian Osteoporosis Drug Market Forecast, 2014-2024
4.9.6 The South Korean Osteoporosis Drug Market Forecast, 2014-2024
4.9.7 The BRICK Countries Osteoporosis Drug Market: Drivers and Restraints, 2014-2024
4.10 The Osteoporosis Drug Market Forecast in the Rest of the World, 2014-2024
4.10.1 Additional Considerations: Challenges for Aging Populations by Region, 2014
5. Global Antiresorptive Drugs Market, 2014-2024
5.1 The Global Antiresorptive Drugs Market Forecast 2014-2024
5.1.1 Breakdown of the Antiresorptive Drugs Market by Drug Category, 2013
5.2 The Global Antiresorptives Drug Market by Drug Category: Sales Forecast 2014-2024
5.3 The Global Bisphosphonates Market, 2013
5.4 The Global Bisphosphonates Drug Market: Sales Forecast 2014-2024
5.5 Breakdown of the Global Bisphosphonates Market: Sales Forecast by Leading Drugs 2014-2024
5.5.1 Actonel/Atelvia (Risedronate)
5.5.1.1 History of Actonel/Atelvia (Risedronate)
5.5.1.2 Generic Competition for Actonel/Atelvia (Risedronate), 2014
5.5.1.3 Actonel/Atelvia (Risedronate) Sales Forecast 2014-2024
5.5.2 Fosamax (Alendronate)
5.5.2.1 History of Fosamax (Alendronate)
5.5.2.2 Generic Competition for Fosamax (Alendronate), 2014
5.5.2.3 Fosamax (Alendronate) Sales Forecast 2014-2024
5.5.3 Reclast/Aclasta (Zoledronic Acid)
5.5.3.1 Reclast/Aclasta (Zoledronic Acid) Strengths and Weaknesses, 2014
5.5.3.2 Reclast/Aclasta (Zoledronic Acid) in the Leading Regional Markets, 2014
5.5.3.3 Generic Competition for Reclast/Aclasta (Zoledronic Acid), 2014
5.5.3.4 Reclast/Aclasta (Zoledronic Acid) Sales Forecast 2014-2024
5.5.4 Boniva (Ibandronate)
5.5.4.1 Boniva (Ibandronate): Sales Forecast 2014-2024
5.6 The Global SERMs Drug Market: Sales Forecast 2014-2024
5.7 Breakdown of the Global SERMs Market: Sales Forecast by Leading Drugs 2014-2024
5.7.1 Evista (Raloxifene)
5.7.1.1 Generic Competition for Evista (Raloxifene), 2014
5.7.1.2 Evista (Raloxifene) Sales Forecast 2014-2024
5.7.2 Duavee/Aprela (Bazedoxifene and Conjugated Estrogens)
5.7.2.1 Duavee/Aprela (Bazedoxifene and Conjugated Estrogens) in the Leading Regional Markets, 2014
5.7.2.2 History of Duavee/Aprela (Bazedoxifene and Conjugated Estrogens)
5.7.2.3 Duavee/Aprela (Bazedoxifene and Conjugated Estrogens) Sales Forecast 2014-2024
5.8 The Global RANKL Antibody Market: Sales Forecast 2014-2024
5.8.1 Prolia (Denosumab)
5.8.1.1 History of Prolia (Denosumab)
5.8.1.2 Prolia to Drive the Market in 2017
5.8.1.3 Safety Profile
5.8.1.4 Prolia: Patent Expiries
5.8.1.5 Prolia (Denosumab) Sales Forecast 2014-2024
5.9 The Global Cathepsin K Inhibitors Market: Sales Forecast 2014-2024
5.9.1 Odanacatib
5.9.1.1 Odanacatib Sales Forecast 2014-2024
5.10 Other Antiresorptive Drugs, 2014
5.10.1 Protelos
5.10.2 Calcitonin-Salmon
5.10.3 Binosto
5.11 Drivers and Restraints for the Global Antiresorptives Drug Market, 2014-2024
6. The Global Anabolic Drugs Market, 2014-2024
6.1 The Global Anabolic Drugs Market, 2013
6.2 The Global Anabolics Drug Market by Drug Category: Sales Forecast 2014-2024
6.3 The Human Recombinant Parathyroid Hormone Peptides Market, 2014
6.3.1 Forteo (Teriparatide) Market: Sales Forecast 2014-2024
6.3.1.1 Forteo Offers a Differentiating Factor in 2014
6.4 The Anti-Sclerostin Market, 2014
6.4.1 Romosozumab: Sales Forecast 2014-2024
6.5 Other Anabolic Drugs
6.5.1 Blosozumab (LY2541546): Second in Class Sclerostin Antibody
6.5.2 ZP-PTH: Parathyroid by Way Micro Needle Patch
6.5.3 ZT-034: Will Need More Than Biomarkers for Approval
6.5.4 Preotact/Preos: Will it be Introduced in the Market Again?
6.5.5 BA-058 (Abaloparatide): Potential Competitor for Forteo
6.5.6 PTH(1-31)NH2: Future Dual-Action Drug
7. Leading Companies in the Osteoporosis Drug Market, 2014
7.1 Leading Companies in the Osteoporosis Drug Market, 2013
7.2 Expected Company Leaders in the OsteoporosisDrug Market in 2024
7.3 Eli Lilly and Co
7.3.1 Eli Lilly Osteoporosis Drug Sales Forecast, 2014-2024
7.4 Amgen
7.4.1 Amgen’s Osteoporosis Product Portfolio
7.4.2 Amgen Osteoporosis Drug Sales Forecast, 2014-2024
7.5 UCB
7.5.1 UCB Osteoporosis Drug Sales Forecast, 2014-2024
7.6 GSK
7.6.1 GSK Osteoporosis Drug Sales Forecast, 2014-2024
7.7 Merck
7.7.1 Merck Osteoporosis Drug Sales Forecast, 2014-2024
7.8 Actavis
7.9 Sanofi
7.10 Pfizer
7.11 Novartis
8. Qualitative Analysis of the Global Osteoporosis Drug Market, 2014-2024
8.1 Pestel Analysis
8.1.1 Political Factors
8.1.2 Economic Factors
8.1.3 Socio-Cultural Factors
8.1.4 Technological Factors
8.1.5 Environmental Factors
8.1.6 Legal Factors
8.2 Porter’s Five Forces Analysis of the Osteoporosis Drugs Market
8.2.1 Competitive Rivalry: High Rivalry Among Competitors
8.2.1.1 Eli Lilly and Amgen Dominate the Biological Osteoporosis Drug Market
8.2.2 Potential Entrants into the Osteoporosis Drug Market: Low Threat of New Entrants
8.2.3 Medium Threat of Substitutes: Who Are The Latent Substitutes?
8.2.4 High Power of Suppliers: Drug Manufacturers Still Have the Power to Lead the Market
8.2.5 High Power of Buyers: Big Pharma to Engulf Smaller Companies
8.3 SWOT Analysis and Strategies
8.3.1 Strengths: Smart Thinking
8.3.2 Weaknesses: Not An Easy Market
8.3.2.1 Patent Expiries
8.3.3 Opportunities: Changing Social Trends
8.3.4 Threats: Highly Stringent but Necessary Regulations
8.3.4.1 Drug Side-Effect Publicity
8.3.4.2 Reimbursement for Bone Metabolism Drugs
8.4 Challenges to Overcome for the Future Osteoporosis Drug Market
9. Expert Opinions
9.1 Interview with Dr. Karl Grindulis, Consultant Rheumatologist at Sandwell General Hospital, West Bromwich, UK
9.1.1 Calcitonin-Salmon in the UK
9.1.2 Personalised Medicine
9.1.3 Expert Views on Romosozumab
9.1.4 Key Factors for the Future
9.2 Interview with Dr. Matthew Drake, Consultant in the Department of Medicine, Division of Endocrinology, Mayo Clinic Rochester, Minnesota, US
9.2.1 Skeletal Anabolic Agents Remain the Biggest Unmet Need
9.2.2 Calcitonin-Salmon: not Recommendable
9.2.3 Shifting to Generics
9.2.4 Romosozumab: Potential Blockbuster
9.2.5 Odanacatib: Intriguing Future Performance
9.2.6 Focusing on Patients with Rare Skeletal Disorders may Give Some Answers
10. Conclusions
10.1 The World Osteoporosis Drug Market by Therapeutic Classes, 2013
10.2 The World Osteoporosis Drug Market Forecast by Drug Category, 2014-2024
10.3 The Global Osteoporosis Drug Market Forecast by Regional Markets, 2014-2024
10.4 The Global Osteoporosis Drug Market Forecast by Leading Drugs, 2014-2024
10.4.1 Leading Companies for the Osteoporosis Drug Market
10.5 Drivers for the Osteoporosis Drugs Market, 2014-2024
【レポート販売概要】
■ タイトル：世界の骨粗しょう症治療・予防市場予測：抗嘔吐薬、骨粗しょう症治療薬、再吸収阻害薬、同化薬■ 英文：Osteoporosis Treatment and Prevention: World Drug Market Forecast 2014-2024 & Future Prospects for Leading Companies
■ 発行日：2014年5月
■ 調査会社：visiongain
■ 商品コード：VISG409054
■ 調査対象地域：グローバル
- Cabot Oil & Gas Corporation：石油・ガスバリューチェーン分析レポート2013Cabot Oil & Gas Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Cabot Oil & Gas Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Cabot Oil & Gas Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value c …
- 再生ポリエチレンテレフタレート（PET）の世界市場：製品別（透明、着色）、最終用途別（繊維、シート・フィルム、梱包材、飲食料品用容器・ボトル）、セグメント別予測The global recycled polyethylene terephthalate market size is anticipated to reach USD 11.40 billion by 2025, according to a new study by Grand View Research, Inc., progressing at a CAGR of 7.4% during the forecast period. Booming beverage industry in Asia Pacific countries such as China, India, Japan, South Korea, Vietnam, and the Philippines has been stimulating the growth of the rPET market. Re …
- 自動車用昼間点灯装置の世界市場2017-2021About Automotive DRL Lighting is one of the most important aspects of an automobile, with vital roles to play in safety, comfort, and, increasingly, in vehicle styling. It includes lighting and signaling devices located in the front, sides, and rear of a vehicle. The primary use of automotive lighting is to ensure visibility for the driver, improve vehicle conspicuity, and intimate the presence an …
- 世界の臨床化学及び免疫診断検査市場：課題、新技術、競争環境“New Frontiers in Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group’s new report, which provides comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and …
- グローバル軍事衛星市場（2014-2024）：地域別分析Synopsis This report offers detailed analysis of the global Military Satellite market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Military Satellite market. Summary "The Global Military Satellite Market 2014-2024 - Country Analysis: Market Profile" provides details of the key markets in ea …
- ペットケアの世界市場：ペットフード、ペットアクセサリー、ペットグルーミングAbout Pet CarePet owners treat their pets as family members and pamper them with a variety of pet food; this is directly contributing to an increase in the sales of pet care products. Pet owners have also started preferring healthy and natural food products for their pets. Therefore, pet food manufacturers are focusing on formulating pet food products with new ingredients to provide better nutriti …
- 低脂肪包装食品の世界市場2018-2022About Reduced Fat Packaged Food The global reduced fat packaged food market is a contributing segment of the global better-for-you (BFY) market. The increasing health consciousness among consumers is increasing the demand for reduced fat food products. The demand for reduced fat packaged food products is expected to remain high during the forecast period. Technavio’s analysts forecast the global r …
- 眼薬の世界市場予測2016-2026What can be expected from the ophthalmic drugs market? Which companies are going to be most successful in the next 10 years? Which therapeutic areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects in the market. Our 334-page report provides 238 tables, charts, and graphs. Discover the most succ …
- 産業用スマートグラスの世界市場2016-2020About Smart Glasses Market for Industrial Applications Smart glasses are AR devices that are widely regarded as the next big technological advance, following Google's launch of the Google Glass project. They are more comfortable to wear and can be used constantly, unlike other devices. Smart glasses are also used for industrial purposes such as reading manuals, checking the status of a system, and …
- 世界自動車産業におけるCFD市場動向（2012-2016）TechNavio's analysts forecast the Global Computational Fluid Dynamics (CFD) market in the Automotive industry to grow at a CAGR of 17.88 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing need to develop superior and competitive products. The Global CFD market in the Automotive industry has also been witnessing an increasing demand for in …
- 有害生物防除サービスの世界市場2017-2021About Pest Control The pest control services industry includes firms that are involved in the professional management of pests, termites, rodents, and other species that can cause health issues or undesired quality of life for humans. The industry caters to both residential customers and commercial establishments. The primary function of pest control services is to maintain hygienic surroundings t …
- 世界のモバイル端末管理市場動向(2014 – 2019)With the rise in the usage of mobile devices by employees at work, the market for mobile device management has grown. This market has adopted and integrated latest technologies considering the significant demands from organizations across all industry verticals. This market involves the implementation of software and security solutions to create a secured mobile environment. The overall mobile dev …
- Stivarga：大腸癌治療薬市場分析Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023”. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on …
- ヘルスケア製品向けコールドチェーン物流サービスの世界市場About Healthcare Cold Chain Logistics Market Healthcare cold chain logistics involves the transportation and distribution of pharmaceutical products that are temperature-sensitive. It helps the Healthcare industry increase the shelf life of various medicines and ensure uninterrupted supply of medicines, equipment, and devices from suppliers and distributors to different locations. TechNavio's anal …
- French Hospital Infectious Disease Testing Market 2014This new report from Venture Planning Group contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. …
